2020
DOI: 10.36946/0869-7922-2020-5-21-31
|View full text |Cite
|
Sign up to set email alerts
|

ON THE NEED FOR THE DEVELOPMENT OF HYGIENIC STANDARDS (MACs) IN THE WATER AND AIR OF THE WORKING AREA FOR PERFLUOROOCTANOIC ACID IN THE RUSSIAN FEDERATION

Abstract: Currently, perfluorooctanoic acid (PFOA) has no hygienic standards in the air of the working area and objects of the human environment in the Russian Federation. By the decision of the Stockholm Convention SC-9/12, PFOA, its salts and derivatives are included in Part I of Annex A of the Stockholm Convention on Persistent Organic Pollutants in 2019 (with exceptions for possible use). The Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
0
0
0
Order By: Relevance
“…Many researchers point out that high uncertainty at the exposure assessment stage might be caused by toxicological parameters being established predominantly in experiments [11][12][13]. In particular, a reference dose, which is considered safe, is calculated based on results of various animal experiments performed on rats, mice, or rabbits [14][15][16][17][18] and then recalculated for the human body using some coefficients [19][20][21][22]. However, the US Food and Drug Administration (US FDA) conducted some studies to compare results of experimental pre-clinical and clinical investigations.…”
mentioning
confidence: 99%
“…Many researchers point out that high uncertainty at the exposure assessment stage might be caused by toxicological parameters being established predominantly in experiments [11][12][13]. In particular, a reference dose, which is considered safe, is calculated based on results of various animal experiments performed on rats, mice, or rabbits [14][15][16][17][18] and then recalculated for the human body using some coefficients [19][20][21][22]. However, the US Food and Drug Administration (US FDA) conducted some studies to compare results of experimental pre-clinical and clinical investigations.…”
mentioning
confidence: 99%
“…Как отмечают многие исследователи, на этапе оценки экспозиции высокая степень неопределенности может быть обусловлена тем, что токсикологические параметры устанавливаются преимущественно в экспериментальных условиях [11-13]. В частности, установление референтного уровня воздействия, считающегося безопасным, рассчитывается по результатам различных опытов на животных (крысах, мышах, кроликах) [14][15][16][17][18], и потом делается перерасчет для человека с использованием ряда коэффициентов [19][20][21][22]. Однако сопоставление экспериментальных доклинических и клинических исследований, по данным Управления по контролю лекарств и пищевых добавок (FDA) США, показало, что около 90 % проанализированных химических соединений, признанных безопасными в ходе этих исследований, демонстрируют высокую токсичность в процессе клинических испытаний.…”
unclassified